The Independent's journalism is supported by our readers. When you purchase through links on our site, we may earn commission.
Indian boy gets world’s most expensive medicine as parents raise £1.5m
Ayaansh Gupta, three, suffering from rare spinal muscular atrophy, treated with Zolgensma at Secunderabad children’s hospital after parents’ social media crowdfunding campaign triumph
Your support helps us to tell the story
This election is still a dead heat, according to most polls. In a fight with such wafer-thin margins, we need reporters on the ground talking to the people Trump and Harris are courting. Your support allows us to keep sending journalists to the story.
The Independent is trusted by 27 million Americans from across the entire political spectrum every month. Unlike many other quality news outlets, we choose not to lock you out of our reporting and analysis with paywalls. But quality journalism must still be paid for.
Help us keep bring these critical stories to light. Your support makes all the difference.
A three-year-old boy from Hyderabad in India suffering from a rare form of spinal muscular atrophy (SMA) has been treated with what is said to be the world’s most expensive drug after tens of thousands of donors responded to his parents’ crowdfunding plea to enable them to purchase it, The Hindustan Times reports.
Ayaansh Gupta was given Zolgensma, a gene therapy medication manufactured by Novartis-owned American biotech company AveXis that was especially imported from the US, after his parents, Yogesh and Rupal Gupta, began a fundraising campaign on social media on 4 February.
By 23 May, the Guptas had already raised INR16 crore (£1.5 million) from some 65,000 donors moved by the story of their son’s plight.
Celebrities including India cricket captain Virat Kohli and his actress wife Anushka Sharma were among those helping the family to reach their fundraising goal by donating generously.
Ayaansh was duly treated with the single-dose intravenous injection at Rainbow Children’s Hospital at Vikrampuri in Secunderabad on Wednesday and kept under close observation before being discharged.
“Except fever, which the doctors say is quite normal for a couple of days, he is absolutely fine,” his father told The Hindustan Times, proudly sporting a “My son has designer genes” T-shirt.
Doctors have advised the family to keep their son in quarantine for two months to avoid complications developing but pronounced the treatment a success.
“Since his immune system is weak, there is a possibility of him getting other infections. The doctors asked us not to allow any visitors,” Mr Gupta explained.
Known by the chemical name onasemnogene abeparvovec, the treatment works by creating a new copy of the gene that makes the human SMN protein, a deficiency of which causes SMA.
Late last month, five-month-old baby Arthur Morgan became the first British child to be treated with Zolgensma at the Evelina London Children's Hospital thanks to the NHS.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments